Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company University of Utah
DescriptionSynthetic peptide derived from cone snail venom
Molecular Target Nicotinic acetylcholine receptor alpha(9)alpha(10)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat chronic pain
Regulatory Designation
PartnerKineta Inc.;
KPI Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today